Evofem Biosciences, Inc. (EVFM)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 03:53PM EDT
Show:
Annual
Cash Flow
All numbers in thousandsBreakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
70,258
-76,698
-205,192
-142,309
-80,033
Depreciation & amortization
918
1,015
1,023
302
263
Stock based compensation
1,850
3,313
8,898
12,697
8,579
Change in working capital
5,996
6,018
10,578
-15,227
-12,673
Accounts receivable
2,106
5,323
-5,382
-1,067
-
Inventory
1,729
1,566
-21
-6,010
-
Accounts Payable
1,913
4,474
-4
4,126
-2,931
Other working capital
-29,374
-70,751
-149,606
-107,083
-55,261
Other non-cash items
3,745
4,274
4,069
2,940
642
Net cash provided by operating activites
-29,265
-70,410
-146,667
-104,829
-55,097
Cash flows from investing activities
Investments in property, plant and equipment
-109
-341
-2,939
-2,254
-164
Purchases of investments
-
-
-
0
-8,233
Sales/Maturities of investments
-
0
0
8,233
-
Net cash used for investing activites
-109
-341
-2,689
6,229
-8,115
Cash flows from financing activities
Debt repayment
0
-5,892
-
0
-4,010
Common stock issued
0
32,320
81,534
107,519
78,360
Common stock repurchased
0
-18
-
-
-
Dividends Paid
-
-
-
-
0
Other financing activites
-
-1,202
-1,297
-3,742
-2,852
Net cash used privided by (used for) financing activities
7,744
61,939
90,693
154,226
78,076
Net change in cash
-21,630
-8,812
-58,663
55,626
14,864
Cash at beginning of period
22,266
13,588
72,251
16,625
1,761
Cash at end of period
636
4,776
13,588
72,251
16,625
Free Cash Flow
Operating Cash Flow
-29,265
-70,410
-146,667
-104,829
-55,097
Capital Expenditure
-109
-341
-2,939
-2,254
-164
Free Cash Flow
-29,374
-70,751
-149,606
-107,083
-55,261
© 2023 Yahoo. All rights reserved.
